| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | Nov 26, 2025 | KalVista Pharmaceuticals, Inc. | CFO | Sell | 42.5 | -4,471 | -29.81% | ✗ | $60.1K |
| May 14, 2021 | May 18, 2021 | Disc Medicine, Inc. | CFO | Buy | 95.0 | +7,655 | 100.00% | ✗ | $72.4K |